Pharma Stocks
-
Assessing Pharma Mar (BME:PHM) Valuation After Zepzelca Milestones And Strong 2025 Growth Update
Pharma Mar (BME:PHM) has drawn fresh attention after its 2025 results update, with management pointing to 27% revenue growth, a…
Read More » -
Ligand Pharmaceuticals Is A Low-Risk Way To Bet On Biopharma Growth: Analyst – Ligand Pharmaceuticals (NASDAQ:LGND)
Bank of America (BofA) Securities on Wednesday initiated coverage on Ligand Pharmaceuticals Inc (NASDAQ:LGND), citing the distinctive royalty firm offers…
Read More » -
The Bull Case For Royalty Pharma (RPRX) Could Change Following Asia Leadership Hire To Target Biotech Royalties
Royalty Pharma plc has appointed Kenneth Sun as Senior Vice President and Head of Asia, effective May 2026, to lead…
Read More » -
What Amneal Pharmaceuticals (AMRX)’s Return to Profitability and 2026 Guidance Means For Shareholders
Amneal Pharmaceuticals recently reported fourth-quarter and full-year 2025 results showing sales rising to US$814.32 million for the quarter and US$3.02…
Read More » -
Why Xenon Pharmaceuticals (XENE) Is Up 38.4% After Strong Phase 3 Azetukalner Seizure Data And FDA Plans
Xenon Pharmaceuticals recently reported positive topline Phase 3 X-TOLE2 results for azetukalner in highly treatment‑resistant focal onset seizures, with both…
Read More » -
Jazz Pharmaceuticals Stock at $185: Here’s Why Analysts See a New All-Time High in 2026
Key Stats for Jazz Pharmaceuticals Stock Past-Week Performance: -4.2% 52-Week Range: $95.5 to $198 Current Price: $185.4 Most investors never…
Read More » -
What Makes Madrigal Pharma (MDGL) One of the Shorted Biotech Stocks to Buy
Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On…
Read More » -
Vaishali Parekh Suggests 3 Intraday Stocks to Buy Today: Paytm, Aurobindo Pharma, DCX Systems
The Indian stock market is facing a period of high volatility. Global geopolitical tensions, rising crude oil prices, and investor…
Read More » -
Reassessing Amneal Pharmaceuticals (AMRX) Valuation After Strong Long Term Returns And A High Current P/E Ratio
Why Amneal Pharmaceuticals Is On Investors’ Radar Today Amneal Pharmaceuticals (AMRX) has caught fresh attention after a period where the…
Read More » -
Assessing Zealand Pharma (CPSE:ZEAL) Valuation After Petrelintide Phase 2 Data And Sharp Share Price Drop
Zealand Pharma (CPSE:ZEAL) is under close watch after Phase 2 topline data for obesity drug candidate petrelintide triggered a sharp…
Read More »